Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Chugai Pharmaceutical Co., Ltd.
  6. News
  7. All News
    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO., LTD.

(4519)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about CHUGAI PHARMACEUTICAL CO., LTD.
10/26Completion of Enrollment in Phase III Comparative Study for Investigational Regenerativ..
PU
10/26CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
10/25CHUGAI PHARMACEUTICAL : Announces 2021 3rd Quarter Results
AQ
10/25CHUGAI PHARMACEUTICAL : Notice of Revisions to Financial Forecasts
AQ
10/25CHUGAI PHARMACEUTICAL : Notice of Revisions to Dividend Forecast for Fiscal Year Ending De..
AQ
10/25CHUGAI PHARMACEUTICAL : Construction of New Bio API Plant for Early Clinical Trials to Acc..
AQ
10/25CHUGAI PHARMACEUTICAL : announced Organizational Changes
AQ
10/25CHUGAI PHARMACEUTICAL : Posts 26% Growth in Nine-Month Attributable Net Income, Raises FY2..
MT
10/25Nikkei 225 Slips 0.7% on Earnings, Election Outlooks
MT
10/25Nikkei slips on soft earnings, U.S. tech worries
RE
10/25PRESS RELEASE : Roche launches comprehensive genomic profiling kit to expand access to per..
DJ
10/24Nikkei drops on soft earnings, U.S. tech worries
RE
10/22PRESS RELEASE : FDA approves Roche's Susvimo, a -2-
DJ
10/22CHUGAI PHARMACEUTICAL : Organizational Changes
PU
10/22CHUGAI PHARMACEUTICAL : Announces 2021 3rd Quarter Results
PU
10/22CHUGAI PHARMACEUTICAL : Notice of Revisions to Financial Forecasts
PU
10/22CHUGAI PHARMACEUTICAL : Notice of Revisions to Dividend Forecast for Fiscal Year Ending De..
PU
10/22CHUGAI PHARMACEUTICAL : Construction of New Bio API Plant for Early Clinical Trials to Acc..
PU
10/22CHUGAI PHARMACEUTICAL : 3Q Results (Jan-Sep 2021)
PU
10/22CHUGAI PHARMACEUTICAL : Supplementary Materials
PU
10/22CHUGAI PHARMACEUTICAL : CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the thi..
PU
10/22CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the..
PU
10/22Chugai Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the Year End..
CI
10/21CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services
AQ
10/21ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Third Quarter Sal..
AQ
10/20Chugai Pharmaceutical, Oncolys BioPharma to Nix Oncolytic Viral Immunotherapy License D..
MT
10/20CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services
PU
10/20CHUGAI PHARMACEUTICAL : F. Hoffmann-La Roche Announces Third Quarter Sales 2021
PU
10/19CHUGAI PHARMACEUTICAL : Atea Announces Update and Topline Results of MOONSONG Study Evalua..
PU
10/19CHUGAI PHARMACEUTICAL : Announces the Decision of the Termination of Exclusive License Agr..
PU
10/19Chugai Pharmaceutical Co., Ltd. Announces the Decision of the Termination of Exclusive ..
CI
10/15PRESS RELEASE : US FDA approves Roche's Tecentriq -2-
DJ
10/15PRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig..
DJ
10/14CHUGAI PHARMACEUTICAL : New Four-year Data Show Sustained Relapse Reduction by Chugai's En..
BU
10/14Chugai Pharmaceutical Co., Ltd. Announces New Longer-Term Efficacy and Safety Data for ..
CI
10/14PRESS RELEASE : New four-year data show Roche's -2-
DJ
10/14PRESS RELEASE : Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for pe..
DJ
10/13SYNAIRGEN : Appoints Chugai Pharma Executive as Chief Regulatory Officer
MT
10/13PRESS RELEASE : Data up to 8-years for Roche's -2-
DJ
10/11ROCHE : Japanese Unit Seeks Regulatory Nod For Additional COVID-19 Monoclonal Antibody Ind..
MT
10/11CHUGAI PHARMACEUTICAL : Files for Additional Indications of Antibody Cocktail Ronapreve fo..
PU
10/05PRESS RELEASE : Roche to present new data on -3-
DJ
10/04CHUGAI PHARMACEUTICAL : Receives Orphan Drug Designation for Hemlibra in Acquired Hemophil..
AQ
10/01CHUGAI PHARMACEUTICAL : Receives Orphan Drug Designation for Hemlibra in Acquired Hemophil..
PU
09/30CHUGAI PHARMACEUTICAL : Roche Announces Results of REGN-COV 2066 Study for Ronapreve for t..
PU
09/30PRESS RELEASE : Phase II/III trial shows -2-
DJ
09/29CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
09/28CHUGAI PHARMACEUTICAL : Zenyaku Kogyo Co. and Chugai Pharmaceutical Co. - Anti-CD20 Monocl..
AQ
09/28CHUGAI PHARMACEUTICAL : Summary
PU
09/27CHUGAI PHARMACEUTICAL : Anti-CD20 Monoclonal Antibody Rituxan Approved for Additional Indi..
PU
09/24PRESS RELEASE : Roche presents new data at World -2-
DJ
09/22PRESS RELEASE : Roche launches three respiratory test panels on cobas 6800/8800 Systems in..
DJ
09/20PRESS RELEASE : New Phase III data support the -2-
DJ
09/17PRESS RELEASE : Roche receives positive CHMP -2-
DJ
09/15PRESS RELEASE : Roche opens access to pathology imaging tools to improve patient care
DJ
09/14PRESS RELEASE : Temedica develops new digital companion Brisa for people with multiple scl..
DJ
09/13CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
09/09PRESS RELEASE : Roche signs definitive share purchase agreement with long-term partner TIB..
DJ
09/08Nikkei 225 Up 0.9%, Tops 30,000, Extends Rally on New Government Hopes
MT
09/08Japan's Nikkei ends at near 6-month high on bargain hunting for cheap stocks
RE
09/07PRESS RELEASE : Roche to present data from -2-
DJ
08/30Nikkei 225 Gains 0.5% on Wall Street Cues, Softer Yen
MT
08/30CHUGAI PHARMACEUTICAL : Script (including Q&A)
PU
08/27PRESS RELEASE : Roche provides update on Tecentriq -2-
DJ
08/25CHUGAI PHARMACEUTICAL : Presentation
PU
08/19Toyota drags Nikkei to 7-month low after output cut report
RE
08/18Japanese shares fall, struggle to shake off Delta variant fears
RE
08/18PRESS RELEASE : Roche receives FDA approval for first companion diagnostic to identify dMM..
DJ
08/18Nikkei snaps 4-day losing streak, but Delta worries persist
RE
08/17Japanese shares bounce back as defensive stocks gain
RE
08/12CHUGAI PHARMACEUTICAL : Launches Evrysdi Dry Syrup 60 mg for the Treatment of Spinal Muscu..
PU
08/12Toshiba CEO Hopes to Vote on New Board Chairman by Year-End
DJ
08/03PRESS RELEASE : US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment f..
DJ
08/02CHUGAI PHARMACEUTICAL : Launches FoundationOne Liquid CDx Cancer Genomic Profile as the Fi..
PU
07/30CHUGAI PHARMACEUTICAL : Continues to be Listed for All ESG Indices Selected by GPIF
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on CHUGAI PHARMACEUTICAL CO., LTD.
Upcoming sector events